Cargando…

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer

BACKGROUND: The thymidine phosphorylase (TP) enzyme has several tumor-promoting functions. The aim of this study was to explore TP gene expression in relation to clinical and histopathological data obtained from patients with stage III colorectal cancer. METHODS AND RESULTS: TP gene expression was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindskog, Elinor B., Wettergren, Yvonne, Odin, Elisabeth, Gustavsson, Bengt, Derwinger, Kristoffer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480868/ https://www.ncbi.nlm.nih.gov/pubmed/23115484 http://dx.doi.org/10.4137/CMO.S10226

Ejemplares similares

Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014)

Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer
por: Kaidi, Donia, et al.
Publicado: (2022)

Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer
por: Taflin, Helena, et al.
Publicado: (2018)

Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer
por: Taflin, Helena, et al.
Publicado: (2022)

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014)

Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal Cancer
por: Taflin, Helena, et al.
Publicado: (2014)

Folate levels measured by LC–MS/MS in patients with colorectal cancer treated with different leucovorin dosages
por: Taflin, Helena, et al.
Publicado: (2014)

A study of lymph node ratio in stage IV colorectal cancer
por: Derwinger, Kristoffer, et al.
Publicado: (2008)

Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
por: Salimzadeh, Hamideh, et al.
Publicado: (2020)

A pharmacokinetic and pharmacodynamic investigation of Modufolin(®) compared to Isovorin(®) after single dose intravenous administration to patients with colon cancer: a randomized study
por: Wettergren, Yvonne, et al.
Publicado: (2014)

A Study of Aspects on Gender and Prognosis in Synchronous Colorectal Cancer
por: Derwinger, Kristoffer, et al.
Publicado: (2011)

Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999)

Research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
por: Ye, Dian-Jun, et al.
Publicado: (2013)

Expression of Thymidine Phosphorylase in Human Gastric Carcinoma
por: Takebayashi, Yuji, et al.
Publicado: (1996)

Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin
por: Taflin, Helena, et al.
Publicado: (2020)

Erratum to research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
por: Ye, Dian-Jun, et al.
Publicado: (2013)

Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer
por: Gustavsson, Bengt, et al.
Publicado: (2015)

Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer
por: OGAWA, MASAICHI, et al.
Publicado: (2014)

The cytosol activity of thymidine phosphorylase in endometrial cancer
por: Miszczak-Zaborska, Elżbieta, et al.
Publicado: (2008)

The Expression of Thymidine Phosphorylase in Cancer-infiltrating Inflammatory Cells in Stomach Cancer
por: Jang, Joung Soon, et al.
Publicado: (2007)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)

Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
por: Szeponik, Louis, et al.
Publicado: (2021)

Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
por: Nie, Xingcao, et al.
Publicado: (2011)

Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer
por: Won, Hye Sung, et al.
Publicado: (2010)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
por: Tamura, Ryosuke, et al.
Publicado: (2014)

Expression of Thymidine Phosphorylase in Primary Human Renal Cell Carcinoma by ELISA Method
por: Kinsui, Hidetoshi, et al.
Publicado: (2002)

Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE
por: Meinders, Marjolein, et al.
Publicado: (2020)

Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase
por: Karamitros, Christos S., et al.
Publicado: (2021)

Thymidine phosphorylase expression and prognosis in colorectal cancer treated with 5-fluorouracil-based chemotherapy: A meta-analysis
por: Che, Jia, et al.
Publicado: (2017)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
por: Toi, M, et al.
Publicado: (2004)

Structures of native human thymidine phosphorylase and in complex with 5-iodouracil
por: Mitsiki, Eirini, et al.
Publicado: (2009)

Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer
por: KIMURA, YUTAKA, et al.
Publicado: (2016)

Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase
por: Harada, Naomoto, et al.
Publicado: (2023)

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix
por: Kabuubi, P, et al.
Publicado: (2006)

Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel
por: Bartsch, Rupert, et al.
Publicado: (2007)

Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase
por: Frontiers Production Office,
Publicado: (2022)

Rare pathogenic mutation in the thymidine phosphorylase gene (TYMP) causing mitochondrial neurogastrointestinal encephalomyelopathy
por: Shah, Syed Asfand Yar, et al.
Publicado: (2022)

Thymidine phosphorylase facilitates retinoic acid inducible gene-I induced endothelial dysfunction
por: Baris, Adrian, et al.
Publicado: (2023)

Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity
por: Paladhi, Ankush, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6m4ir7vdsvj2c733cd1teth4bs